The US Food and Drug Administration approved 50 new molecular entities in 2024 —just five fewer than it did in 2023. Last ...

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

Washington researchers and care providers are struggling to keep up with new chemicals in the region’s illicit drug supply.

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...